Analytical Data
-
基因名
SLA
- Application
-
别名
hSLAP; SLA 1; sla; SLA1; SLAP 1; SLAP; SLAP-1; SLAP1; SLAP1_HUMAN; Src like adapter; Src like adapter protein 1; Src like adaptor; SRC-like-adapter; Src-like-adapter protein 1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q13239
-
表达区间
2-276 aa
-
氨基酸序列
GNSMKSTPA PAERPLPNPE GLDSDFLAVL SDYPSPDISP PIFRRGEKLR VISDEGGWWK AISLSTGRES YIPGICVARV YHGWLFEGLG RDKAEELLQL PDTKVGSFMI RESETKKGFY SLSVRHRQVK HYRIFRLPNN WYYISPRLTF QCLEDLVNHY SEVADGLCCV LTTPCLTQST AAPAVRASSS PVTLRQKTVD WRRVSRLQED PEGTENPLGV DESLFSYGLR ESIASYLSLT SEDNTSFDRK KKSISLMYGG SKRKSSFFSS PPYFED
-
分子量
31.1 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SLA (Streptolysin S-like) reorganized proteins have garnered significant attention in recent years due to their unique structural and functional characteristics. These proteins are primarily produced by certain bacterial species and play key roles in pathogenesis, particularly in evading host immune responses. The understanding of SLA proteins has been propelled by advancements in molecular biology and structural biology techniques, allowing researchers to unveil their intricate mechanisms and interactions at the molecular level. Furthermore, the potential of these proteins in therapeutic applications, such as vaccine development and targeted drug delivery, has spurred extensive research efforts. Studies have highlighted how SLA proteins modulate cellular pathways and influence host marker expression, making them critical for understanding bacterial virulence and host-pathogen interactions. As such, the exploration of SLA restructured proteins promises not only to enhance our understanding of bacterial biology but also to provide valuable insights into the development of novel therapeutic strategies for infectious diseases.
